Cure My Disease

Don't miss your cure!

 Log in / Sign up

Video coaching from home: a new approach to help preterm babies catch up on motor skills

NCT ID NCT07725367

Disease control Sponsor: Medipol University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether a family-centered early intervention program called the Homeostasis-Enrichment-Plasticity (HEP®) approach, delivered through weekly online sessions and home activities over 12 weeks, can improve motor development in preterm infants at risk for developmental delay. Researchers will compare infants receiving the HEP® program with those receiving usual care, measuring motor skills, sensory function, and parental well-being. The goal is to see if telerehabilitation can be an effective, accessible early intervention strategy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a family-centered early intervention program called the Homeostasis-Enrichment-Plasticity (HEP®) approach, delivered via weekly online sessions and home activities over 12 weeks
What this could lead to
If effective, this telerehabilitation program could offer a practical, home-based early intervention to improve motor development and reduce delays in preterm infants.
What could go wrong
This is a small, early-stage trial with only 32 infants, so results may not apply broadly. The intervention requires active parent participation, which may be challenging for some families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

32 people

The number who actually took part.

Started

Feb 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 12 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Corrected age 4-12 months. Born at or before 36 weeks and 6 days of gestation. Parents willing to participate regularly and provide informed consent. Exclusion Criteria Major visual or hearing impairment. Genetic syndrome or congenital anomaly. Medical conditions preventing active participation (e.g., oxygen dependency). Participation in another experimental rehabilitation study during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Developmental delays are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Developmental delays Prematurity

Contacts and locations

Locations

  • Istanbul Medipol University, Kavacık Campus

    Istanbul, Istanbul, 34810, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.